Eltrombopag oral tablet is available as a brand-name drug. It’s not available as a generic drug. Brand name: Promacta. Eltrombopag comes in two forms: oral tablet and oral suspension. Eltrombopag oral ...

SAN DIEGO -- Treatment with eltrombopag (Promacta) for pediatric patients with newly diagnosed immune thrombocytopenia (ITP) led to a significantly higher rate of durable platelet response compared ...

Current second-line treatments for immune thrombocytopenia (ITP) require long-term administration. Ianalumab, a monoclonal antibody targeting B cells, is being assessed as a short-course second-line ...

In 2008, the FDA approved two new orphan drugs, romiplostim and eltrombopag, for the treatment of chronic adult idiopathic thrombocytopenic purpura, marking a significant change in treatment of the ...

Eltrombopag is an oral thrombopoietin-receptor agonist. This study evaluated the efficacy of eltrombopag for increasing platelet counts and reducing the need for platelet transfusions in patients with ...

A thrombopoietin agonist raises platelet counts in HCV-positive patients who are undergoing antiviral therapy. Cirrhotic patients who are infected with hepatitis C virus (HCV) often experience ...

Review the side-effects of Eltrombopag as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the ...

Please provide your email address to receive an email when new articles are posted on . Eltrombopag increased response rates when added to standard immunosuppressive therapy among patients with ...

The Appraisal Committee reviewed the data available on the clinical and cost effectiveness of eltrombopag, having considered evidence on the nature of chronic immune thrombocytopenia (ITP) and the ...

Learn everything you need to know about Eltrombopag-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side effects, precautions, warnings ...